Huntington National Bank’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2
Closed -$1K 2069
2022
Q1
$1K Buy
+2
New +$1.21K ﹤0.01% 1951

Other funds holding CDLX

Huntington National Bank's CDLX Position: Q2 2022 in Review

Huntington National Bank sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 2 shares — an estimated $1K sold.

Huntington National Bank first reported a position in CDLX in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • Huntington National Bank reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • Huntington National Bank sold 2 Cardlytics shares in Q2 2022, an estimated $1K.
  • Huntington National Bank first reported a position in Cardlytics in Q1 2022 and held it in 1 quarter.
  • Huntington National Bank's Cardlytics position peaked at $1K in Q1 2022.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on Huntington National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.